Cue Biopharma, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 21 →Insiders1 insider bought $99,719 in 5 open-market buys. No sales.→HoldersBleichroeder 7.1%Driehaus 5.6%Vanguard 3.1%→Financing →PeersClosest companies: CRIS, SPRO, RIGL→
From the filings
Figures
- Revenue
- $37.7Mlast 12 months
- Net income
- −$164.1Mlast 12 months
- Operating cash flow
- −$24.5Mlast 12 months
- Cash and equivalents
- $17.4Mat the last balance sheet
- Shares outstanding
- 5.2M shareson issue